Combination Therapies to Target EphA2 and EGFR Expressing Tumors.
Date
2023-06-26
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
ORCID
0000-0001-8462-6681
Type
Thesis
Degree Level
Masters
This item is under an embargo.
Access to the abstract and all associated documents will not be permitted until 2026-06-26.
Description
Keywords
EphA2, comparative oncology, osteosarcoma, tumor initiating cells
Citation
Degree
Master of Science (M.Sc.)
Department
Pathology and Laboratory Medicine
Program
Biochemistry